Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-016543
Filing Date
2026-04-14
Accepted
2026-04-14 16:05:16
Documents
19
Period of Report
2026-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 758943
2 GRAPHIC formdef14a_001.jpg GRAPHIC 24438
3 GRAPHIC formdef14a_002.jpg GRAPHIC 19516
4 GRAPHIC proxy_001.jpg GRAPHIC 455399
5 GRAPHIC proxy_002.jpg GRAPHIC 356341
  Complete submission text file 0001493152-26-016543.txt   3598730

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE envb-20251231.xsd EX-101.SCH 5165
7 XBRL DEFINITION FILE envb-20251231_def.xml EX-101.DEF 7340
8 XBRL LABEL FILE envb-20251231_lab.xml EX-101.LAB 58475
9 XBRL PRESENTATION FILE envb-20251231_pre.xml EX-101.PRE 44543
22 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 123449
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 (617) 444-8400
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38286 | Film No.: 26860864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)